相关实验视频
Updated: Jul 28, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
第1型糖尿病概述和手术期间管理
Grace B Nelson1, Kathryn M Sumpter1
1Pediatrics, University of Tennessee Health Science Center, 49 North Dunlap Street, Memphis, TN 38105, USA.
The Orthopedic clinics of North America
|June 4, 2023
概括
由于代谢压力,手术期间的1型糖尿病 (T1D) 管理是复杂的. 先进的糖尿病技术可以帮助维持T1D住院患者的葡萄糖控制.
科学领域:
- 内分泌学 在内分泌学.
- 代谢医学是一种代谢医学.
- 糖尿病 技术 技术
背景情况:
- 1型糖尿病 (T1D) 是一个日益严重的全球健康问题.
- 现代T1D治疗方法,包括胰岛素类似物和技术,增加了治疗方案的复杂性.
- 外科手术和麻醉诱导代谢压力,导致患者的葡萄糖显著变化.
研究的目的:
- 突出在手术过程中管理T1D的挑战.
- 强调当前糖尿病技术在缓解葡萄糖波动方面的潜力.
- 倡导在医院和手术环境中整合先进的T1D管理工具.
主要方法:
- 关于T1D管理,代谢应激反应和糖尿病技术的当前文献的综述.
- 分析手术和麻醉对T1D患者葡萄糖代谢的影响.
- 讨论血糖控制的算法和监测策略.
主要成果:
- 手术应激反应显著增加T1D患者的葡萄糖变异性.
- 密切监测葡萄糖和结构化胰岛素算法可以管理这些反应.
- 新兴的糖尿病技术在维持血糖控制方面表现有前途.
结论:
- 住院治疗和手术对T1D患者来说,具有独特的血糖控制挑战.
- 先进的糖尿病技术为管理这些时期的葡萄糖变化提供了可行的解决方案.
- 建议在T1D管理的外科环境中增加糖尿病技术的考虑和实施.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Diabetes: Symptoms, Diagnosis, and Complications
605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Insulin: Dosing Regimen and Adverse Effects
216
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
216

